ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
January 27, 2025 Cover
Volume 103, Issue 2
After a breakdown in US-Russia relations, Riken finds itself ahead of its rivals. And Lawrence Berkeley National Laboratory chases element 120
After a breakdown in US-Russia relations, Riken finds itself ahead of its rivals. And Lawrence Berkeley National Laboratory chases element 120
The agency gave its nod to almost as many new molecular entities last year as it did in 2023
Home and personal care firms have cut 1,4-dioxane levels in products to 1 ppm, but is that good enough?
The computational chemistry firm Schrödinger argues that AI isn’t enough in drug discovery
To have impact, the plan must advance a bold vision of safer, more sustainable chemicals and processes at scale
Chemical educator and Compound Interest blogger Andy Brunning explores the blockbuster weight-loss drugs called GLP-1 receptor agonists.
Hundreds associated with nearby universities and government labs have lost homes